Pulmonary Hypertension Registry of Kerala, India (PRO-KERALA): One-year outcomes.

Autor:	Harikrishnan S; Department of Cardiology, SCTIMST, Trivandrum, India. Electronic address: drharikrishnan@outlook.com., Mani A; Department of Cardiology, SCTIMST, Trivandrum, India., G S; SCTIMST, Trivandrum, India., M A; Malabar Institute of Medical Sciences, Calicut, India., Menon J; Amrita Institute of Medical Sciences, Kochi, India., G R; Medical College, Calicut, India., Kumar RK; Amrita Institute of Medical Sciences, Kochi, India., Koshy AG; Medical College, Trivandrum, India., Attacheril TV; Lourde Hospital, Ernakulam, India., George R; Medical College, Kottayam, India., Punnose E; MOSC Medical College, Kolencherry, India., Ashraf SM; Academy of Medical Sciences, Pariyaram, India., Sr A; General Hospital, Trivandrum, India., Cholakkal M; IQRAA Hospital, Calicut, India., Jeemon P; SCTIMST, Trivandrum, India., Joseph S; Little Flower Hospital, Ernakulam, India., Govindan U; Jubilee Mission Medical College, Thrissur, India., Joseph J; Caritas Hospital,Kottayam, India., Eapen K; Samaritan Hospital, Aluva, India., Sreedharan M; NIMS Trivandrum, India., Kumar A; Koilyil Hospital, Kannur, India., Venugopal K; Pushpagiri Medical College, Thiruvalla, India.
Jazyk:	angličtina
Zdroj:	Indian heart journal [Indian Heart J] 2022 Jan-Feb; Vol. 74 (1), pp. 34-39. Date of Electronic Publication: 2021 Dec 14.
DOI:	10.1016/j.ihj.2021.12.002
Abstrakt:	Background: Short term outcomes of patients with pulmonary hypertension are not available from low and middle-income countries including India. Methods: We conducted a prospective study of 2003 patients with pulmonary hypertension, from 50 centres (PROKERALA) in Kerala, who were followed up for one year. Pulmonary hypertension (PH) was mainly diagnosed on the basis of Doppler echocardiography. The primary outcome was a composite end-point of all-cause death and hospital admission for heart failure. All cause hospitalisation events constituted the secondary outcome. Results: Mean age of study population was 56 ± 16 years. Group 1 and Group 2 PH categories constituted 21.2% and 59% of the study population, respectively. Nearly two-thirds (65%) of the study participants had functional class II symptoms. 31% of Group 1 PH patients were on specific vasodilator drugs.In total, 83 patients (4.1%) died during the one-year follow-up period. Further, 1235 re-hospitalisation events (61.7%) were reported. In the multivariate model, baseline NYHA class III/IV (OR 1.87, 95% C.I. 1.35-2.56), use of calcium channel blockers (OR 0.18, 95% C.I. 0.04-0.77), vasodilator therapy (OR 0.5, 95% C.I. 0.28-0.87) and antiplatelet agents (OR 1.80, 95% C.I. 1.29-2.51) were associated with primary composite outcome at one-year (p < 0.05). Conclusion: In the PROKERALA registry, annual mortality rate was 4%. More than half of the patients reported re-hospitalisation events on follow up. Uptake of guideline directed therapies were suboptimal in the study population. Quality improvement programmes to improve guideline directed therapy may improve clinical outcomes of PH patients in India. Competing Interests: Declaration of competing interest None of the authors have any conflict of Interests to declare. (Copyright © 2021 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu